Incannex Healthcare Inc (IXHL) Quarterly Institutional 13F Update (Q2 2026)

IXHL ranks #8935 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

IXHL is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

16 institutions disclose a position in IXHL, but none treat it as a major bet — even AdvisorShares Investments LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

IXHL is down 2.1% today, but institutions show net buying of $1.2M this quarter — a divergence between today's price move and the underlying institutional flow.

IXHL reported a net loss of $19.3M in its latest fiscal year.

• Not yet profitable — net loss of $19.3M in the latest fiscal year
• Revenue declined 100.0% year over year
• Net income improved year over year, from -$46.9M to -$19.3M
• Operating cash flow was negative, using $12.9M in cash
• Current ratio of 48.81x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.08x equity — within a conventional range